Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.
This week, I am speaking with Greg Kubin, co-host of the Business Trip Podcast and co-founder and partner at PsyMed Ventures, a fund investing in frontier mental health technologies and treatments.
Greg and I chat pretty regularly, sometimes weekly, about the state of play in psychedelics, neurotech, investing, consciousness, and a rapidly changing world.
As an early-stage investor in frontier mental health and wellness technologies, Greg has a unique lens into what future approaches and landscapes might look like.
A recent focus in my writing has been the ‘emergent paradigms’ afoot that are nearing—or achieved—tipping points in their acceptance and application; in this conversation, Greg and I discuss a handful of these topics, including:
* The Gut-Brain-Axis and the innovations afoot in diagnostics and precision pre & probiotics
* Metabolic Health, its impact on mental health, and tools like the ketogenic diet
* Neurotechnology and Brain-Computer Interface for diagnostics and therapeutics
We also discuss:
* The origin story of PsyMed Ventures and the Business Trip Podcast
* The pharmaceutical industrial complex
* The relationship between academic research and commercialization and the archetype of the “Entrepreneurial Scientist.”
As well as many colorful tangents, digressions, and detours.
And now, I bring you my conversation with Greg Kubin.
Listen to the episode on Substack, Spotify, Google or Apple.
Credits:
* Hosted by Zach Haigney
* Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari
* Find us at thetripreport.com
* Follow us on Instagram, Twitter, LinkedIn and YouTube
* Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit
www.thetripreport.com
